Biomarkers in Liver Disease: Emerging Methods and Potential Applications

Biomarkers in Liver Disease: Emerging Methods and Potential Applications

Saved in:

Bibliographic Details
Main Authors:	Guruprasad P. Aithal, Neil Guha, Jonathan Fallowfield, Laurent Castera, Andrew P. Jackson
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	International Journal of Hepatology
Online Access:	http://dx.doi.org/10.1155/2012/437508
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The development of a food-group, tree classification method and its use in exploring dietary associations with metabolic dysfunction-associated Steatotic liver disease (MASLD) and other health-related outcomes in a UK population
by: Amina A. Alawadi, et al.
Published: (2025-03-01)

Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography
by: Guruprasad P Aithal, et al.
Published: (2015-05-01)

Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
by: Gilles Duvoisin, et al.
Published: (2017-01-01)

miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD)
by: Parthana Rani Sutradhar, et al.
Published: (2024-01-01)

Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases
by: Wenkuan Li, et al.
Published: (2022-01-01)

Potential Biomarkers of the Earliest Clinical Stages of Parkinson’s Disease
by: Anelya Kh. Alieva, et al.
Published: (2015-01-01)

Rheumatic Diseases and Obesity: Adipocytokines as Potential Comorbidity Biomarkers for Cardiovascular Diseases
by: Rossana Scrivo, et al.
Published: (2013-01-01)

Volatile Organic Metabolites as Potential Biomarkers for Genitourinary Cancers: Review of the Applications and Detection Methods
by: Kiana L. Holbrook, et al.
Published: (2025-01-01)

Serum albumin: a potential biomarker for liver involvement in SARS-CoV-2 infection
by: Neha Gupta, et al.
Published: (2025-02-01)

TDP-43 as a potential retinal biomarker for neurodegenerative diseases
by: Margit Glashutter, et al.
Published: (2025-02-01)

Identification of Potential Biomarkers for Coronary Artery Disease Based on Cuproptosis
by: Bohong Zhang, et al.
Published: (2023-01-01)

Potential of albumin dialysis at terminal liver failure in patients with chronic liver diseases
by: O. E. Nikiforova, et al.
Published: (2010-08-01)

Gut Microbiota as Emerging Players in the Development of Alcohol-Related Liver Disease
by: Wei Li, et al.
Published: (2024-12-01)

Salivary Cytokines as Potential Diagnostic Biomarkers for Systemic Lupus Erythematosus Disease
by: Zeineb Zian, et al.
Published: (2021-01-01)

Complex application of mathematical methods in diagnostics of diffuse liver diseases
by: I. Yu. Pirogova, et al.
Published: (2011-02-01)

Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms
by: Fengyuan Li, et al.
Published: (2016-01-01)

Application of glycyrrhizinic acid in treatment of patients with alcoholic liver disease
by: I. G. Nikitin, et al.
Published: (2009-02-01)

Exploring the Potential Imaging Biomarkers for Parkinson’s Disease Using Machine Learning Approach
by: Illia Mushta, et al.
Published: (2024-12-01)

Optical Coherence Tomography in Huntington's Disease—A Potential Future Biomarker for Neurodegeneration?
by: Clancy Cerejo, et al.
Published: (2025-01-01)

Identifying plasma exosome antigens as a potential diagnostic biomarker for tuberculosis disease
by: Yan Jiang, et al.
Published: (2025-01-01)

Identification of biomarkers associated with coronary artery disease and non-alcoholic fatty liver disease by bioinformatics analysis and machine learning
by: Chuan Lu, et al.
Published: (2025-01-01)

Serum dihomo-g-linolenic acid concentration as a potential novel noninvasive biomarker for liver steatosis detection in children
by: Natalia Kopiczko, et al.
Published: (2024-12-01)

Monitoring for 5-aminosalicylate nephrotoxicity in adults with inflammatory bowel disease: prognostic model development and validation using data from the Clinical Practice Research Datalink
by: Abhishek Abhishek, et al.
Published: (2025-01-01)

Emerging biotechnologies for engineering liver organoids
by: Junqi Zhao, et al.
Published: (2025-03-01)

Serum adropin levels as a potential biomarker for predicting diabetic kidney disease progression
by: I-Wen Chen, et al.
Published: (2025-02-01)

Comment on “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review”
by: Nicholas-Paul Delicata, et al.
Published: (2016-01-01)

Serum IL-18 Is a Potential Biomarker for Predicting Severe Dengue Disease Progression
by: Josephine Diony Nanda, et al.
Published: (2021-01-01)

Urinary Microvesicle-Bound Uromodulin: A Potential Molecular Biomarker in Diabetic Kidney Disease
by: Neng-jun Lou, et al.
Published: (2017-01-01)

SIRI and SII as potential biomarkers of disease activity and lupus nephritis in systemic lupus erythematosus
by: Chi-Hui Yang, et al.
Published: (2025-01-01)

Neurogranin in Alzheimer's Disease: Roles in synaptic function, pathology, and potential as a diagnostic biomarker
by: Rajkumar Bavaharini, et al.
Published: (2024-09-01)

Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant Recipients
by: Mamatha Bhat, et al.
Published: (2017-01-01)

Imaging Diagnostics, Biomarkers, and Emerging Trends in Orthopedic Research and Treatment
by: Gabriela Oliwia Trestka, et al.
Published: (2025-01-01)

Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients
by: Justin Y. Tang, et al.
Published: (2018-01-01)

Update on Ppar𝜸 and Nonalcoholic Fatty Liver Disease
by: Gene P. Ables
Published: (2012-01-01)

The emerging role of blood-based biomarkers in early detection of colorectal cancer: A systematic review
by: Faris Shweikeh, et al.
Published: (2024-01-01)

Pan-cancer analysis shows that TNFSF4 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including liver cancer
by: Zhaoda Deng, et al.
Published: (2025-01-01)

The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review
by: Seyedeh Alia Moosavian, et al.
Published: (2021-01-01)

Is There a Role for Probiotics in Liver Disease?
by: Robert S. Lo, et al.
Published: (2014-01-01)

Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections
by: Maura Rojas-Pirela, et al.
Published: (2025-02-01)

Potential biomarkers in Behçet’s disease: monocyte, neutrophil, platelet, and C-reactive protein to albumin ratios
by: Mestan Sahin, et al.
Published: (2024-11-01)